Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1025-1031

  Meng, Fan Su ^a   Su, Lei ^a   Tang, You Qing ^a   Wen, Qiang ^a   Liu, Yun Song ^a   Liu, Zhi Feng ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

C reactive protein; Intensive care unit; Procalcitonin; Semi quantitative PCT Q test; Short term mortality

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; INOTROPIC AGENT; PROCALCITONIN;

ADULT; APACHE; ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RESPIRATORY FAILURE; SEPSIS;

APACHE; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; DEMOGRAPHY; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; PROTEIN PRECURSORS; ROC CURVE; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67349127628     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.03.012     Document Type: Article

References (30)

1. Rivers E.P., McIntyre L., Morro D.C., and Rivers K.K. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 173 (2005) 1054-1065
2. Chan Y.L., Tseng C.P., Tsay P.K., Chang S.S., Chiu T.F., and Chen J.C. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit. Care 8 (2004) R12-20
3. Lobo S.M.A., Lobo F.R.M., Bota D.P., Lpes-Ferreira F., Soliman H.M., Melot C., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123 (2003) 2043-2049
4. Rocker G., Cook D., Sjokvist P., Weaver B., Finfer S., McDonald E., et al. Clinician predictions of intensive care unit mortality. Crit. Care Med. 32 (2004) 1149-1154
5. ten Boekel E., Vroonhof K., Huisman A., van Kampen C., and de Kieviet W. Clinical laboratory findings associated with in-hospital mortality. Clin. Chim. Acta 372 (2006) 1-13
6. Schneider H.G., and Lam Q.T. Procalcitonin for the clinical laboratory: a review. Pathology 39 (2007) 383-390
7. Becker K.L., Snider R., and Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit. Care Med. 36 (2008) 941-952
8. Muller B. Endocrine aspects of critical illness. Ann. Endocrinol. (Paris) 68 (2007) 290-298
9. Clec'h C., Ferrier F., Karoubi P., Fosse J.P., Cupa M., Hoang P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit. Care Med. 32 (2004) 1166-1169
10. Sponholz C., Sakr Y., Reinhart K., and Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit. Care 20 (2006) R145
11. Muthiah K.A., Rachakonda K.S., Davis M.J., Simmons E.G., Schier G., and Gil F.S. Prospective evaluation of procalcitonin in sepsis in the Illawarra area of Australia: PEPSIA study. Crit. Care Resusc. 9 (2007) 137-142
12. Kushimoto S., Shibata Y., Koido Y., Kawai M., Yokota H., and Yamamoto Y. The clinical usefulness of procalcitonin measurement for assessing the severity of infection in critically ill patients requiring corticosteroid therapy. Nippon Med. Sch. 74 (2007) 236-240
13. Nobre V., Harbarth S., Graf J.D., Rohner P., and Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am. J. Respir. Crit. Care Med. 177 (2008) 498-505
14. Nylen E.S., Whang K.T., Snider Jr. R.J., Steinwald P.M., White J.C., and Becker K.L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit. Care Med. 26 (1998) 1001-1006
15. Rau B., Kruger C.M., and Schilling M.K. Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch. Surg. 389 (2004) 134-144
16. Casado-Flores J., Blanco-Quiros A., Nieto M., Asensio J., and Fernandez C. Prognostic utility of the semi-quantitative procalcitonin test, neutrophil count and C-reactive protein in meningococcal infection in children. Eur. J. Pediatr. 165 (2006) 26-29
17. Boo N.Y., Nor Azlina A.A., and Rohana J. Usefulness of a semi-quantitative procalcitonin test kit for early diagnosis of neonatal sepsis. Singap. Med. J. 49 (2008) 204-208
18. Ramsthaler F., Kettner M., Mall G., and Bratzke H. The use of rapid diagnostic test of procalcitonin serum levels for the postmortem diagnosis of sepsis. Forensic Sci. Int. 178 (2008) 139-145
19. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20 (1992) 864-874
20. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., and Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 23 (1995) 1638-1652
21. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 13 (1985) 818-829
22. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit. Care Med. 26 (1998) 1767-1768
23. Randolph A.G., Guyatt G.H., and Carlet J. Understanding articles comparing outcomes among intensive care units to rate quality of care. Evidence Based Medicine in Critical Care Group. Crit. Care Med. 26 4 (1998) 773-781
24. Dorizzi R.M., Polati E., Sette P., Ferrari A., Rizzotti P., and Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin. Biochem. 39 (2006) 1138-1143
25. Giamarellos-Bourboulis E.J., Giannopoulou P., Grecka P., Voros D., Mandragos K., and Giamarellou H. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?. J. Crit. Care 19 (2004) 152-157
26. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., and Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit. Care Med. 34 (2006) 2596-2602
27. Dahaba A.A., Hagara B., Fall A., Rehak P.H., List W.F., and Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br. J. Anaesth. 97 (2006) 503-508
28. Tang B.M., Eslick G.D., Craig J.C., and McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect. Dis. 7 (2007) 210-217
29. Meisner M., Brunkhorst F.M., Reith H.B., Schmidt J., Lestin H.G., and Reinhart K. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin. Chem. Lab. Med. 28 (2000) 989
30. Kordek A., Podraza W., and Czajka R. Reliability of semiquantitative determination of procalcitonin serum concentrations in neonates. Diagn. Microbiol. Infect. Dis. 56 (2006) 31-34